HB1061
To Ensure That Individuals With Gestational Diabetes Are Provided Coverage For Continuous Glucose Monitors Under The Arkansas Medicaid Program.
Last Action (Dec. 10, 2024): WITHDRAWN BY AUTHOR
Sponsors
AI-Generated Summary
House Bill 1061 amends existing Arkansas law regarding coverage for continuous glucose monitors (CGMs) under the Arkansas Medicaid program. The bill explicitly adds a diagnosis of gestational diabetes to the list of conditions that qualify an individual for Medicaid-covered CGM devices. To qualify, patients must also commit to regular follow-up visits with a healthcare provider at least every six months to evaluate the ongoing clinical benefit of the monitor. This legislation aims to expand access to monitoring technology for pregnant individuals experiencing gestational diabetes.
Potential Impact Analysis
Who Might Benefit?
The primary beneficiaries are individuals covered by the Arkansas Medicaid program who are diagnosed with gestational diabetes, as they would gain insurance coverage for continuous glucose monitoring devices to manage their health during pregnancy. Additionally, healthcare providers who treat these patients may benefit from improved patient outcomes and more effective glucose management tools.
Who Might Suffer?
The primary entity negatively impacted is the Arkansas state budget, as the expansion of Medicaid coverage to include continuous glucose monitors for patients with gestational diabetes will likely result in increased state expenditures for the Medicaid program. Taxpayers may also be indirectly affected by the potential increase in program costs.
Get Notified
Receive an email when this bill's status changes.